MYC overexpression is associated with an early disease progression from MDS to AML
David Gajzer, Constantine Logothetis, David A. Sallman, Gregoire Calon, Abida Babu, Onyee Chan, Nicole D. Vincelette, Virginia O. Volpe, Najla H. Al Ali, Pukhraz Basra, Chetasi Talati, Andrew Kuykendall, Qianxing Mo, Eric Padron, Kendra Sweet, Rami S. Komrokji, Jeffrey E. Lancet, Seongseok Yun, Ling Zhang
Topics & Concepts
IDH1Bone marrowCancer researchMedicineOncologyInternal medicineTumor progressionImmunohistochemistryMyelodysplastic syndromesMyeloidHematologyCancerSurvival analysisBiologyGeneMutationGeneticsAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell Transplantation